← FDA DRUG APPROVALS

FDA ANDA · ANDA076168

OXYCODONE HYDROCHLORIDE

Sponsor: TEVA

APPLICATION
ANDA076168
TYPE
ANDA
LATEST ACTION
2004-05-25
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
None (Tentative Approval)

Products

OXYCODONE HYDROCHLORIDENone (Tentative Approval)
OXYCODONE HYDROCHLORIDE 80MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2004-05-25Labeling · Supplement 2AP
2003-09-29OriginalLabelTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →